Apollo Hospitals plans to improve its AI tool for predicting cardiovascular disease risks through a new collaboration with Solventum Health Information Systems. Solventum’s patient classification and quality methodologies will be integrated with Apollo’s Cardiovascular Disease Risk technology. The enhancements should strengthen Apollo’s ability to identify patients at high risk of complications and additional hospitalisations.
Y chromosome loss creates hidden cancer vulnerability in men
A study initiated by a University of Arizona Cancer Center physician-scientist Dr. Dan Theodorescu revealed that the loss of the Y chromosome in men’s body
